Status:
COMPLETED
Open-Label Study of ARD-0403 in Testosterone Deficient Men
Lead Sponsor:
Ardana Bioscience Ltd
Conditions:
Hypogonadism
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient wellbeing. The purpose of this study is to investi...
Eligibility Criteria
Inclusion
- Testosterone deficiency
Exclusion
- Previous treatment with testosterone replacement therapy within 4 weeks
- Moderate-severe benign prostatic hypertrophy, or prostatic cancer
- Haematocrit \>50%
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00448955
Start Date
May 1 2007
End Date
February 1 2008
Last Update
April 18 2008
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Affiliated Research Center, Inc
Huntsville, Alabama, United States, 35801
2
Stanford University
Stanford, California, United States, 94305-5826
3
Los Angeles Biomedical Research Institute at Harbor-UCLA
Torrance, California, United States, 90502
4
Northwestern University
Chicago, Illinois, United States, 60611-3008